#122 - Lisa Purcell & Alina Baum

KGI: Innovation in Applied Life Sciences & Healthcare

内容由Keck Graduate Institute (KGI) and Keck Graduate Institute提供。所有播客内容（包括剧集、图形和播客描述）均由 Keck Graduate Institute (KGI) and Keck Graduate Institute 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

3+ y ago 51:42

MP3•单集首页

已归档的系列专辑 ("不活跃的收取点" status)

When? This feed was archived on July 28, 2023 09:02 (9M ago). Last successful fetch was on June 27, 2023 13:06 (10M ago)

Why? 不活跃的收取点 status. 我们的伺服器已尝试了一段时间，但仍然无法截取有效的播客收取点

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

As part of KGI's Industry Speaker Series, Trustee Ross Grossman interviewed two Regeneron leaders: Dr. Lisa Purcell, Senior Manager, Clinical Sciences, Immunology and Inflammation, and Dr. Alina Baum, Senior Staff Scientist.

Lisa Purcell joined Regeneron in 2008 and is a Clinical Scientist in Immunology and Inflammation. She received her PhD from McGill University and completed her Postdoctoral Training at Columbia University. Dr. Purcell’s current work focuses on the clinical development of therapies within the immunology and infectious disease therapeutic areas, including those for SARS-CoV-2/COVID-19. She has also developed therapies for pathogens using Regeneron’s novel technologies. Dr. Purcell is the scientific director of Regeneron’s science education efforts, including the Regeneron Science Talent Search, research mentorship efforts, the International and Westchester Science and Engineering Fair, and STEM teacher programs.

Alina Baum is a Senior Staff Scientist at Regeneron Pharmaceuticals where she is leading the COVID-19 spike antibody program currently in clinical trials. She received her PhD in molecular virology from the lab of Adolfo Garcia-Sastre at Mount Sinai School of Medicine and performed postdoctoral studies with Charlie Rice at Rockefeller University. Her academic career focused on studying interactions between RNA viruses and the innate immune system. In her current position at Regeneron, she is leading a virology research group developing novel therapies for viral infections including influenza and hepatitis B, and emerging pathogens such as Ebola and SARS-CoV-2, as well as the development of oncolytic viruses and vaccines for cancer immunotherapy.

100集单集